Uterine smooth muscle tumors of uncertain malignant potential: a retrospective evaluation of clinical pathology and immunohistochemistry features

Table 3 Comparison of clinical features between the STUMP and leiomyoma groups

Feature	Total	STUMPs	Leiomyomas	p-value
Age (year), n (%)
< 50	37 (82.2%)	18 (85.7%)	19 (79.2%)	0.57^†
> 50	8 (17.8%)	3 (14.3%)	5 (20.8%)	0.57^†
Gravid, n (%)
0	14 (31.1%)	7 (33.3%)	7 (29.2%)	0.87^†
1–3	12 (26.7%)	6 (25%)	6 (25%)
≥ 3	19 (42.2%)	8 (38.1%)	11 (45.8%)
Menopause status, n (%)
Yes	2 (4.4%)	1 (4.8%)	1 (4.2%)	> 0.99^*
No	43 (95.6%)	20 (95.2%)	23 (95.8%)	> 0.99^*
History of radiotherapy, n (%)
Yes	1 (2.2%)	1 (4.8%)	0 (0%)	0.47^*
No	44 (97.8%)	20 (95.2%)	24 (100%)	0.47^*
PMHx
Yes	1 (2.2%)	1 (4.8%)	0 (0%)	0.47^*
No	44 (97.8%)	20 (95.2%)	24 (100%)	0.47^*
Type of operation, n (%)
Myomectomy	15 (33.3%)	5 (23.8%)	10 (41.7%)	0.11^*
TAH	9 (20%)	6 (28.6%)	3 (12.5%)
BSO or USO	18 (40%)	7 (33.3%)	11 (45.8%)
Omentectomy	3 (6.7%)	3 (14.3%)	0 (0%)

TAH total abdominal hysterectomy, BSO bilateral salpingo-oophorectomy, USO unilateral salpingo-oophorectomy, PMHx past medical history
^*Exact Fisher test
^†Chi-square test

ISSN: 2520-8454